GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Fresenius SE & Co KGaA (XTER:FRE) » Definitions » YoY Rev. per Sh. Growth

Fresenius SE KGaA (XTER:FRE) YoY Rev. per Sh. Growth : 0.14% (As of Dec. 2023)


View and export this data going back to 1992. Start your Free Trial

What is Fresenius SE KGaA YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Fresenius SE KGaA's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2023 was 0.14%.

Fresenius SE KGaA's Revenue per Share for the three months ended in Dec. 2023 was €10.08.


Fresenius SE KGaA YoY Rev. per Sh. Growth Historical Data

The historical data trend for Fresenius SE KGaA's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fresenius SE KGaA YoY Rev. per Sh. Growth Chart

Fresenius SE KGaA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY Rev. per Sh. Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.58 2.39 3.54 -42.93 3.20

Fresenius SE KGaA Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -43.59 4.31 9.20 2.32 0.14

Fresenius SE KGaA YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Fresenius SE KGaA's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY Rev. per Sh. Growth (A: Dec. 2023 )
=(Revenue per Share (A: Dec. 2023 )-Revenue per Share (A: Dec. 2022 ))/ | Revenue per Share (A: Dec. 2022 ) |
=(39.591-38.363)/ | 38.363 |
=3.20 %

Fresenius SE KGaA's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2023 is calculated as:

YoY Rev. per Sh. Growth (Q: Dec. 2023 )
=(Revenue per Share (Q: Dec. 2023 )-Revenue per Share (Q: Dec. 2022 )) / | Revenue per Share (Q: Dec. 2022 )) |
=(10.081-10.067)/ | 10.067 |
=0.14 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fresenius SE KGaA YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Fresenius SE KGaA's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Fresenius SE KGaA (XTER:FRE) Business Description

Address
Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius SE is a healthcare holding company based in Germany with four segments. The company owns a large stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals and fertility clinics in Germany, Spain, and Latin America. Vamed provides a variety of services such as healthcare facility construction and operation management, including post-acute care rehabilitation.
Executives
Dr. Michael Moser Board of Directors
Sara Hennicken Board of Directors
Michael Sen Board of Directors
Dr. Francesco De Meo Board of Directors
Stephan Sturm Board of Directors
Wolfgang Kirsch Supervisory Board
Mats Henriksson Board of Directors
Dr. Gerd Krick Supervisory Board

Fresenius SE KGaA (XTER:FRE) Headlines

No Headlines